• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 11 of 100
FDA announces new rules to make TV drug ads clearer as Trump nominates RFK Jr., who wants to ban them
Health
FDA announces new rules to make TV drug ads clearer as Trump nominates RFK Jr., who wants to ban them
By Matthew Perrone and The Associated PressNovember 15, 2024
businessman wearing a suit with his arms crossed posed for a photo
Newsletters
Why this major drugmaker no longer has an ‘IT department’
By John KellNovember 13, 2024
Why Eli Lilly’s CEO says failing faster is essential to the company’s success
Leadership
Why Eli Lilly’s CEO says failing faster is essential to the company’s success
By Fortune EditorsNovember 13, 2024
AstraZeneca says it’s taking China’s investigations into fraud, illegal drug importation and data collection ‘very seriously’
Retail
AstraZeneca says it’s taking China’s investigations into fraud, illegal drug importation and data collection ‘very seriously’
By AFPNovember 12, 2024
Robert F. Kennedy Jr. speaks during a campaign rally for Republican presidential nominee, former President Donald Trump at Macomb Community College in Michigan.
Politics
RFK Jr. could play a big role under Trump—and Big Pharma is sounding the alarm: ‘We need somebody grounded by science and evidence, not somebody who rejects it’
By Christiaan HetznerNovember 8, 2024
AstraZeneca’s China chief detained in illegal data collection and drug import probe, pharma giant says
Leadership
AstraZeneca’s China chief detained in illegal data collection and drug import probe, pharma giant says
By AFPNovember 7, 2024
Many hundred of spectators watch Queen Margrethe of Denmark while the Royal Guard takes her through the city of Kalundborg in a coach during her visit to the city where she commence a two days visit on June 13, 2017 in Kalundborg, Denmark.
Lifestyle
Danish manufacturing hub of weight-loss wonderdrug Ozempic is an epicenter for childhood overweightedness
By Ryan HoggNovember 4, 2024
Jo Natauri’s Invidia Capital seeks $850 million for first fund
Finance
Jo Natauri’s Invidia Capital seeks $850 million for first fund
By Luisa BeltranOctober 31, 2024
British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance
Retail
British pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance
By AFPOctober 30, 2024
A hand is seen holding Ozempic.
Health
Novo’s main Ozempic plant cited for quality lapses by FDA
By Madison Muller and BloombergOctober 29, 2024
Top aging expert says these 4 FDA-approved drugs hold promise for extending life
Health
Top aging expert says these 4 FDA-approved drugs hold promise for extending life
By Alexa MikhailOctober 29, 2024
Sanofi profit lifted by early vaccine sales, dupixent growth
Finance
Sanofi profit lifted by early vaccine sales, dupixent growth
By Ashleigh Furlong, Tim Loh and BloombergOctober 25, 2024
As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
Commentary
As activist Starboard engages constructively, here’s a potent prescription for Pfizer’s future success under Dr. Bourla’s watch
By Jeffrey Sonnenfeld and Steven TianOctober 24, 2024
Just 25% of people at high risk of pneumococcal disease—children younger than 2, adults older than 64, and those with certain chronic health conditions such as diabetes—have been immunized, according to an August 2024 survey by the National Foundation for Infectious Diseases.
Health
Pneumonia can be a deadly complication of COVID, the flu, and RSV: What to know about pneumococcal vaccination
By Lindsey LeakeOctober 22, 2024
How Merck leveled up its cybersecurity strategy since the NotPetya cyberattack that led to a $1.4 billion dispute
Leadership
How Merck leveled up its cybersecurity strategy since the NotPetya cyberattack that led to a $1.4 billion dispute
By John KellOctober 22, 2024
1...
  • 9
  • 10
  • 11
  • 12
  • 13
...100
Most Popular
Europe
‘It’s only when you see 49-ton trucks in China running on batteries that you realize how serious electrification is’: Octopus Energy CEO Greg Jackson on Europe’s incumbency problemplaceholder alt text
By Kamal AhmedOctober 30, 2026
Real Estate
The Pentagon and Britain are bracing for the power to go out. The ultrawealthy got there first, with backup generators, escape homes, and stockpilesplaceholder alt text
By Sydney LakeOctober 30, 2026
North America
Pentagon orders bases to plan for 90 days without the grid as Britain urges families to stockpile food and waterplaceholder alt text
By Bilin LinOctober 26, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.